FDA Inspection 1029456 — KRS Global Biotechnology, Inc

KRS Global Biotechnology, Inc — FEI 3006412304

The FDA completed an inspection of KRS Global Biotechnology, Inc on October 23, 2017 in Boca Raton, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 23, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boca Raton, FL (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
188521 CFR 211.165(b)Microbiological testing
202721 CFR 211.192Investigations of discrepancies, failures